New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Microtome Market to Exhibit Growth at a CAGR of ~6% by 2032 | DelveInsight
The rising demand for microtomes is largely driven by the growing prevalence of chronic conditions like cancer, cardiovascular diseases such as atherosclerosis, myocardial infarction, and cardiomyopathies, as well as respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Furthermore, the global expansion of biomedical research and pharmaceutical development is also contributing to the increased need for microtomes.
DelveInsight’s Microtome Market Insights report provides the current and forecast market analysis, individual leading microtome companies’ market shares, challenges, microtome market drivers, barriers, trends, and key market microtome companies in the market.
Key Takeaways from the Microtome Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global microtome market during the forecast period.
- In the technology segment of the microtome market, the fully automated category of microtome had a significant revenue share in 2024.
- Notable microtome companies such as Thermo Fisher Scientific Inc, AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgeräte GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd, Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and several others, are currently operating in the microtome market.
- In February 2023, Precisionary Instruments launched a brand new line of rotatory microtome and offered 3 models for the same; RF-600: Manual model, RF-800: Semi-automated model, RF-1000: Fully automated model.
To read more about the latest highlights related to the microtome market, get a snapshot of the key highlights entailed in the Global Microtome Market Report
Microtome Overview
A microtome is a precision cutting instrument used in scientific research, primarily in histology and pathology, to slice thin sections of biological tissues for microscopic examination. The device works by precisely slicing specimens, often embedded in paraffin or another medium, into sections that are typically between 1 and 50 micrometers thick. These thin slices are mounted onto glass slides for further staining and analysis under a microscope. Microtomes can be either manual or motorized, with motorized models offering enhanced precision and ease of use, especially when preparing large volumes of samples.
The microtome operates through a sharp blade that moves across the specimen, guided by the user or an automated system. Different types of microtomes are designed for various applications, such as rotary microtomes for general tissue sectioning, cryostats for cutting frozen tissue, and sliding microtomes for harder materials. Accurate sectioning with a microtome is crucial for obtaining high-quality tissue samples, which are essential for diagnosing diseases, conducting research, and understanding cellular structures. The technology has evolved significantly over time, offering improved consistency, reproducibility, and speed in scientific studies.
Microtome Market Insights
North America held the largest share of the microtome market in 2024, compared to other regions. This is attributed to the ongoing rise in cancer cases, increasing rates of myocardial infarction, and the prevalence of various lung-related diseases such as COPD. Additionally, the region's advanced medical infrastructure, ready access to state-of-the-art equipment, growing opportunities for advanced cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, increased healthcare spending, and the presence of numerous market players are all expected to drive the growth of the microtome market in North America.
As per DelveInsight’s estimations, the total diagnosed prevalent cases of COPD in the US was around 18.3 million in 2023 and is projected to increase during the forecast period owing to the increasing prevalence of smoking, improved diagnosis, and increasing awareness among the patient population. In addition, in 2023, the US recorded approximately 26 million diagnosed prevalent cases of asthma, this figure is projected to grow by 2034.
These conditions highlight the rising demand for microtomes in diagnostic pathology due to their ability to produce high-quality lung tissue sections for microscopic examination, which is crucial for diagnosing, understanding, and treating these diseases. This, in turn, will further support the growth of the microtome market.
Therefore, the combination of these factors is anticipated to fuel the expansion of the microtome market in North America from 2024 to 2030.
To know more about why North America is leading the market growth in the microtome market, get a snapshot of the Microtome Market Outlook
The microtome market has experienced significant growth in recent years, driven by advancements in the fields of histology, biotechnology, and pathology. Microtomes, essential instruments used for slicing thin sections of tissue samples for microscopic analysis, are increasingly in demand due to the rising prevalence of diseases such as cancer and the growing need for research in drug development and diagnostics. The increasing number of laboratories and research facilities, along with the growing emphasis on personalized medicine, has further stimulated market growth. Additionally, there is an increasing adoption of automation and digital technologies in microtome systems, which has enhanced efficiency and precision, making the instruments more appealing to a broader range of end-users.
Key factors influencing the microtome market include technological innovations, including the development of motorized microtomes, which have revolutionized tissue sectioning by improving reproducibility and reducing manual errors. Companies are also focusing on the development of advanced features such as user-friendly interfaces, high precision, and quick sample preparation times to meet the growing demand for high-quality diagnostic results. These innovations are particularly important in the fields of molecular biology and genomics, where precise and consistent sectioning is critical for accurate analysis.
Furthermore, the microtome market is witnessing a trend toward the adoption of more environmentally friendly and cost-effective solutions. As laboratory budgets are often under pressure, the need for more affordable options that do not compromise on performance is increasing. The rise in public-private partnerships and funding for medical research is expected to play a crucial role in supporting market expansion, providing the necessary resources for advancements in microtome technology and its applications in medical research.
Get a sneak peek at the microtome market dynamics @ Microtome Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| Microtome Market CAGR | ~6% |
| Key Microtome Companies | Thermo Fisher Scientific Inc, AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgeräte GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd, Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others |
Microtome Market Assessment
- Microtome Market Segmentation
- Microtome Market Segmentation By Product: Microtome (Rotary Microtome, Vibrating Microtome, and Others) and Accessories (Blades and Knives, Cooling Clamp, Others)
- Microtome Market Segmentation By Technology: Fully Automated, Semi-Automated, and Manual
- Microtome Market Segmentation By End-User: Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others
- Microtome Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the microtome market are set to emerge as the trendsetter explore @ Microtome Companies
Table of Contents
| 1 | Microtome Market Report Introduction |
| 2 | Microtome Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Microtome Market Key Factors Analysis |
| 6 | Microtome Market Porter’s Five Forces Analysis |
| 7 | Microtome Market Layout |
| 8 | Microtome Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the microtome market by 2032? Click to get a snapshot of the Microtome Market Trends
Related Reports
Asthma Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key asthma companies including GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharmaceuticals, Avillion, Pearl Therapeutics, ARS Pharmaceuticals, Sinomab, Avalo Therapeutics, Kymab, Sanofi, Cumberland Pharmaceuticals, Genentech, Inc., among others.
Asthma Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key asthma companies, including Jiangsu Hengrui Medicine, GlaxoSmithKline, Immunotek SL, AB Science, EMS, Avalo Therapeutics, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., ARS Pharmaceuticals, Sanofi, Zura Bio Ltd., AstraZeneca, EURRUS Biotech GmbH, T-Balance Therapeutics GmbH, Gossamer Bio, Aldeyra Therapeutics, Inc., Trio Medicines, Janssen Research & Development, Arrowhead Pharmaceuticals, Hoffman-La-Roche, GlaxoSmithKline, Biohaven Pharmaceutical, TAK-Circulator Co., Shanghai Hengrui Pharmaceutical, among others.
Acute Respiratory Distress Syndrome Market
Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ARDS companies, including MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals, Athersys, Healios, Direct Biologics, Biohaven Pharmaceutical, Arch Biopartners, APEPTICO Forschung und Entwicklung GmbH, Staidson (Beijing) Biopharmaceuticals, Veru, Mesoblast Limited, Avalo Therapeutics, Pluristem Therapeutics, ILTOO Pharma, among others.
Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key chronic obstructive pulmonary disease companies, including Genentech, Inc., GlaxoSmithKline, Verona Pharma plc, Regeneron Pharmaceuticals, Sanofi, MedImmune LLC, EpiEndo Pharmaceuticals, Tetherex Pharmaceuticals, AstraZeneca, Chiesi Farmaceutici S.p.A., Synairgen Research Ltd., Mereo Biopharma, Organicell Regenerative Medicine, Pulmotect, Inc., Inmunotek S.L., PULMATRiX, GLENMARK PHARMACEUTICALS LTD, Dimerix Limited, ProterixBio, among others.
Chronic Obstructive Pulmonary Disease Pipeline
Chronic Obstructive Pulmonary Disease Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key COPD companies, including Sanofi, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Verona Pharma plc, Immunotek, Yungjin Pharm. Co., Ltd., Pulmotect, Inc., Tetherex Pharmaceutical, CSL Behring, AstraZeneca, Novartis, Genentech, Vertex Pharmaceuticals, EmeraMed, Afimmune, Mereo BioPharma, Synairgen, Adamis Pharmaceuticals, Quercegen Pharmaceuticals LLC, Regend Therapeutics, Meridigen Biotech Co., Ltd., Pulmatrix, Eisai, GlaxoSmithKline, EpiEndo Pharmaceuticals, 3SBio, OmniSpirant, Foresee Pharmaceuticals, Amgen, Organicell Regenerative Medicine, Arrowhead Pharmaceuticals, ProterixBio, RS BioTherapeutics, MitoRx, C4X Discovery, Respiratorius, ARK biosciences, Incannex, GNI Pharma, Celon pharma, Alveolus Bio, Kinaset therapeutics, Landos Biopharma, Parion Sciences, KeyMed Biosciences, Bioneer corporation, AlgiPharma, Palobiofarma, Dimerix Bioscience, Glenmark Pharmaceuticals, among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
